Note 5 - Stockholders' Equity (Deficit) (Details 2) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Allocated Share-based Compensation Expense | $ 243,000 | $ 153,000 | $ 407,000 | $ 164,000 |
| Research and Development Expense [Member] | ||||
| Allocated Share-based Compensation Expense | 17,000 | 61,000 | 32,000 | 64,000 |
| General and Administrative Expense [Member] | ||||
| Allocated Share-based Compensation Expense | $ 226,000 | $ 92,000 | $ 375,000 | $ 100,000 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|